Evidence map›Paper›PMID 37570573›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Laser-Ablative Synthesis of Silicon-Iron Composite Nanoparticles for Theranostic Applications.

Alexander A Bubnov, Vladimir S Belov, Yulia V Kargina, Gleb V Tikhonowski, Anton A Popov, Alexander Yu Kharin, Mikhail V Shestakov, Alexander M Perepukhov, Alexander V Syuy, Valentyn S Volkov and 4 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alexander A BubnovInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.ORCID 0000-0002-5877-6982
Vladimir S BelovInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.
Yulia V KarginaInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.
Gleb V TikhonowskiInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.ORCID 0000-0003-4998-1631
Anton A PopovInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.
Alexander Yu KharinInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.
Mikhail V ShestakovInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.ORCID 0000-0002-3246-1368
Alexander M PerepukhovMoscow Institute of Physics and Technology, Dolgoprudny, 141700 Moscow Region, Russia.
Alexander V SyuyMoscow Institute of Physics and Technology, Dolgoprudny, 141700 Moscow Region, Russia.ORCID 0000-0002-2373-8812
Valentyn S VolkovMoscow Institute of Physics and Technology, Dolgoprudny, 141700 Moscow Region, Russia.ORCID 0000-0003-2637-1371
Vladimir V KhovayloDepartment of Functional Nanosystems and High-Temperature Materials, National University of Science and Technology MISIS, Leninskiy Prospekt 4, 119049 Moscow, Russia.ORCID 0000-0001-7815-100X
Sergey M KlimentovInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.
Andrei V KabashinLP3, Aix Marseille University, CNRS, Campus de Luminy, Case 917, 13288 Marseille, France.ORCID 0000-0003-1549-7198
Victor Yu TimoshenkoInstitute of Engineering Physics for Biomedicine (PhysBio), National Nuclear Research University MEPhI, 115409 Moscow, Russia.ORCID 0000-0003-3234-1427

Funding

Innovation Protection Fund 17260GU/2022Ministry of Science and Higher Education of the Russian Federation 075-15-2021-606Ministry of Science and Higher Education of the Russian Federation FSWU-2020-0035Russian Science Foundation 21-12-00405
6 · The paper itself

Abstract

The combination of photothermal and magnetic functionalities in one biocompatible nanoformulation forms an attractive basis for developing multifunctional agents for biomedical theranostics. Here, we report the fabrication of silicon-iron (Si-Fe) composite nanoparticles (NPs) for theranostic applications by using a method of femtosecond laser ablation in acetone from a mixed target combining silicon and iron. The NPs were then transferred to water for subsequent biological use. From structural analyses, it was shown that the formed Si-Fe NPs have a spherical shape and sizes ranging from 5 to 150 nm, with the presence of two characteristic maxima around 20 nm and 90 nm in the size distribution. They are mostly composed of silicon with the presence of a significant iron silicide content and iron oxide inclusions. Our studies also show that the NPs exhibit magnetic properties due to the presence of iron ions in their composition, which makes the formation of contrast in magnetic resonance imaging (MRI) possible, as it is verified by magnetic resonance relaxometry at the proton resonance frequency. In addition, the Si-Fe NPs are characterized by strong optical absorption in the window of relative transparency of bio-tissue (650-950 nm). Benefiting from such absorption, the Si-Fe NPs provide strong photoheating in their aqueous suspensions under continuous wave laser excitation at 808 nm. The NP-induced photoheating is described by a photothermal conversion efficiency of 33-42%, which is approximately 3.0-3.3 times larger than that for pure laser-synthesized Si NPs, and it is explained by the presence of iron silicide in the NP composition. Combining the strong photothermal effect and MRI functionality, the synthesized Si-Fe NPs promise a major advancement of modalities for cancer theranostics, including MRI-guided photothermal therapy and surgery.

Indexed as

composite nanoparticlesiron silicidelaser ablation in liquidsmagnetic resonance imagingphotothermal therapysilicontheranostics

Identifiers

PMID37570573
PMCPMC10421319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.